JO
DARE icon

John Overdeck’s Dare Bioscience DARE Stock Holding History

John Overdeck’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,279
Closed -$24.2K – 5125
2026
Q1 		$24.2K Sell
13,279
-19,757
-60% -$33.8K ﹤0.01% 4504
2025
Q4 		$63.8K Buy
+33,036
New +$65.9K ﹤0.01% 3907
2022
Q1 		– Sell
-12,927
Closed -$310K – 3044
2021
Q4 		$310K Buy
12,927
+11,865
+1,117% +$244K ﹤0.01% 3623
2021
Q3 		$21K Buy
+1,062
New +$20.9K ﹤0.01% 4167
2021
Q1 		– Sell
-2,433
Closed -$39K – 3894
2020
Q4 		$39K Buy
+2,433
New +$34.1K ﹤0.01% 3260

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

John Overdeck's DARE Position: Q2 2026 in Review

John Overdeck sold out of Dare Bioscience (DARE) in Q2 2026, closing a stake of 13,279 shares — an estimated $24.2K sold.

John Overdeck first reported a position in DARE in Q4 2020 and held it in 5 quarters. The position peaked at $310K in Q4 2021. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • John Overdeck reported no remaining Dare Bioscience position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 13,279 Dare Bioscience shares in Q2 2026, an estimated $24.2K.
  • John Overdeck first reported a position in Dare Bioscience in Q4 2020 and held it in 5 quarters.
  • John Overdeck's Dare Bioscience position peaked at $310K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.